| ISIN | LU2207278404 |
|---|---|
| Valor Number | 120730677 |
| Bloomberg Global ID | |
| Fund Name | Kieger Impact Healthcare Fund Class A CHF (H) Accumulating |
| Fund Provider |
Kieger AG
Kieger AG Limmatstrasse 264, CH-8005 Zürich Phone: +41 44 444 18 44 Web: https://kieger.com/ E-Mail: info@kieger.com |
| Fund Provider | Kieger AG |
| Representative in Switzerland |
ACOLIN Fund Services AG Zürich Phone: +41 44 396 96 96 |
| Distributor(s) | |
| Asset Class | Equities |
| EFC Category | |
| Distribution Policy | Accumulation |
| Home Country | Luxembourg |
| Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
| Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
| Investment Strategy *** | The investment objective of the Sub-Fund is to achieve long term capital growth by principally investing in equities of healthcare and healthcare related companies or issuers worldwide (including Emerging Markets) with a focus on issuers that contribute to the realisation of the healthcare related United Nations Sustainable Development Goals ("SDGs"). No guarantee can be given that the investment objective will be achieved. |
| Peculiarities |
| Current Price * | 81.72 CHF | 11.12.2025 |
|---|---|---|
| Previous Price * | 80.84 CHF | 10.12.2025 |
| 52 Week High * | 89.00 CHF | 30.01.2025 |
| 52 Week Low * | 72.46 CHF | 07.08.2025 |
| NAV * | 81.72 CHF | 11.12.2025 |
| Issue Price * | ||
| Redemption Price * | ||
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 55,681,733 | |
| Unit/Share Assets *** | 1,011,770 | |
| Trading Information SIX | ||
| YTD Performance | +2.04% |
31.12.2024 - 11.12.2025
31.12.2024 11.12.2025 |
|---|---|---|
| 1 month | +4.27% |
11.11.2025 - 11.12.2025
11.11.2025 11.12.2025 |
| 3 months | +5.79% |
11.09.2025 - 11.12.2025
11.09.2025 11.12.2025 |
| 6 months | -0.97% |
11.06.2025 - 11.12.2025
11.06.2025 11.12.2025 |
| 1 year | -3.32% |
11.12.2024 - 11.12.2025
11.12.2024 11.12.2025 |
| 2 years | -4.15% |
11.12.2023 - 11.12.2025
11.12.2023 11.12.2025 |
| 3 years | -19.11% |
12.12.2022 - 11.12.2025
12.12.2022 11.12.2025 |
| 5 years | -18.28% |
31.08.2022 - 11.12.2025
31.08.2022 11.12.2025 |
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Centene Corp | 4.19% | |
|---|---|---|
| Revvity Inc | 4.00% | |
| Hikma Pharmaceuticals PLC | 3.82% | |
| RadNet Inc | 3.81% | |
| Hologic Inc | 3.70% | |
| Exact Sciences Corp | 3.60% | |
| Novo Nordisk AS Class B | 3.59% | |
| ResMed Inc | 3.58% | |
| Humana Inc | 3.56% | |
| Sanofi SA | 3.54% | |
| Last data update | 30.09.2025 | |
| TER *** | 1.27% |
|---|---|
| TER date *** | 30.09.2023 |
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | 1.00% |
| Ongoing Charges *** | 1.59% |
|
SRRI ***
|
|
| SRRI date *** | 30.09.2022 |